iAnthus Capital Holdings, Inc. IAN

Company Overview

iAnthus Capital Holdings, Inc. is a cannabis company focused on the cultivation, processing, distribution, and retail sale of medical and adult-use cannabis products in the United States. The company operates in the regulated cannabis industry through a portfolio of state-level licenses, dispensaries, cultivation facilities, and branded products. Its business model has historically centered on vertically integrated cannabis operations, allowing it to participate across multiple stages of the cannabis value chain, including cultivation, manufacturing, wholesale distribution, and direct-to-consumer retail sales.

The company evolved through acquisitions and multi-state expansion following its formation in Canada and subsequent listing on the Canadian Securities Exchange. iAnthus expanded aggressively during the late 2010s through acquisitions including MPX Bioceutical Corporation, which significantly increased its operational footprint in the U.S. cannabis market. Following rapid expansion, the company underwent financial restructuring and recapitalization efforts beginning in 2020 amid liquidity challenges affecting the broader cannabis sector. Its strategic positioning has emphasized regulated U.S. cannabis markets with limited-license structures and vertically integrated operations.